Tags » Pharmaceuticals

Press Release: Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication

Press Release: Tekmira’s Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication Tekmira’s Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication Data From Animal Model Demonstrates Complete…

Read more…

Pharmaceuticals

In the Eye of the Beholder: Dueling Descriptions in Allergan, Valeant Suits -- WSJ Blog

By David Benoit In the fight over Allergan Inc., the two sides are in disagreement even when trying to explain what they do. In filing dueling lawsuits in recent days, Allergan and its adversaries –Valeant Pharmaceuticals Inc. 9 more words

Pharmaceuticals

UK's WOODFORD: New Fund on Track to Hit Return Target -- Market Talk

1617 GMT Star fund manager Neil Woodford says his new Equity Income Fund, run by Woodford Investment Management, is on track to meet–if not surpass–a target of securing a 4% dividend yield by next year. 15 more words

Pharmaceuticals

UK's WOODFORD: More M&A in Healthcare, Telecoms to Come -- Market Talk

1616 GMT Fund manager Neil Woodford expects merger and acquisition activity to accelerate over the coming months, “especially in pharmaceuticals but also more broadly in the healthcare sector.” The renowned fund manager, who publicly opposed Pfizer’s (PFE) takeover bid for AstraZeneca…

Read more…

Pharmaceuticals

Sources: Mylan Makes Second Round of Bidding for Glaxo Mature Drug Portfolio

LONDON–U.S. generic drugs company Mylan Inc., private equity groups TPG Capital LLP, Advent International, KKR & Co L.P., and Warburg Pincus LLC, and some Indian drug makers have made it through to the second round of bidding for a portfolio of mature drugs being sold by GlaxoSmithKline PLC,…

Read more…

Pharmaceuticals

Sources: Mylan Makes Second Round of Bidding for Glaxo Mature Drug Portfolio -Update

By Hester Plumridge LONDON–U.S. generic drugs company Mylan Inc., private equity groups TPG Capital LLP, Advent International, KKR & Co L.P., and Warburg Pincus LLC, and some Indian drug makers have made it through to the second round of bidding for a portfolio of mature drugs…

Read more…

Pharmaceuticals